A study of plasma bicalutamide concentrations in hemodialysis patients.

about

A study of plasma bicalutamide concentrations in hemodialysis patients.

Item

http://www.wikidata.org/entity/Q47297865

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

A study of plasma bicalutamide concentrations in hemodialysis patients.

@en

A study of plasma bicalutamide concentrations in hemodialysis patients.

@nl

type

Item

label

A study of plasma bicalutamide concentrations in hemodialysis patients.

@en

A study of plasma bicalutamide concentrations in hemodialysis patients.

@nl

prefLabel

A study of plasma bicalutamide concentrations in hemodialysis patients.

@en

A study of plasma bicalutamide concentrations in hemodialysis patients.

@nl

P1476

A study of plasma bicalutamide concentrations in hemodialysis patients.

@en

P2093

Fumio Ito

http://www.w3.org/2001/XMLSchema#string

Hayakazu Nakazawa

http://www.w3.org/2001/XMLSchema#string

Kazuo Kubo

http://www.w3.org/2001/XMLSchema#string

Keiko Suzuki

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Goya

http://www.w3.org/2001/XMLSchema#string

Takeshi Kihara

http://www.w3.org/2001/XMLSchema#string

Toshiaki Suzuki

http://www.w3.org/2001/XMLSchema#string

P2860

Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group.

Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study

Increased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan.

P304

162-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000339919

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22868217

http://www.w3.org/2001/XMLSchema#string